Amplitude Ventures focuses on healthcare companies, primarily investing in Series B rounds. The firm operates across Canada with offices in Montreal, Toronto, and Vancouver. Amplitude's investment strategy centers on scaling Canadian companies with global potential, typically deploying capital from their $200 million fund launched in 2019.

Notable portfolio companies include Celsius Therapeutics, Evommune, and Tentarix Biotherapeutics. Amplitude's team brings extensive experience in private and public markets, having raised over $700 million in equity capital since 2012. The firm applies an evidence-based approach to investing, aiming to build world-class management teams and drive breakout potential in their portfolio companies.